Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.76 USD | +0.74% | -1.57% | -18.88% |
04:49pm | TD Cowen Adjusts Price Target on Gilead Sciences to $85 From $90 | MT |
04:23pm | Jefferies Adjusts Gilead Sciences' Price Target to $80 From $95 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.88% | 81.39B | |
+25.96% | 653B | |
+27.00% | 556B | |
-6.57% | 354B | |
+20.43% | 331B | |
+2.92% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-5.90% | 144B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead Sciences : Says EMA Validates Marketing Authorization Application for HIV-1 Treatment Candidate